Skip to content

Early Physical Therapy Intervention in Preterm Infants

Early Physical Therapy Intervention in Preterm Infants During the Stay in the Neonatal Intensive Care Unit and at Home to Promote Motor Development

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03313427
Enrollment
48
Registered
2017-10-18
Start date
2017-12-01
Completion date
2019-12-01
Last updated
2019-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Intervention, Home, Motor Development, NICU, Physical Therapy, Preterm Infant

Brief summary

The hypothesis of this study is that early physical therapy intervention, initiated during the NICU stay and up to 2 months corrected age, based on the family-centered model, could promote preterm infants motor development in short-term (2 months corrected age) and long-term (8 months corrected age). There is a high evidence level of different systematic reviews, which support the effectivity of early intervention with preterm infants. The principal aim of this randomized controlled trial is to evaluate the effectiveness of early physiotherapy intervention to promote motor development in preterm infants at 2 and 8 months corrected age. The secondary purpose is to study the motor development of those preterm infants who received early physical therapy intervention.

Interventions

OTHERPhysical Therapy Early Intervention

At the UCIN: * Parental education to empower them on motor development and parent-infant relationship. Consisted on 6 sessions during the first weeks at the NICU. * Tactile and kinaesthetic stimulation managed by parents. 2 times a day, 15 minutes each, during 10 days. At home: Psychomotor Development Program for the baby; comprised of different exercises, in different phases, depending on child maturation stage. Started after hospital discharge until 2 months corrected age.

OTHERUsual Care

NICU usual care

Sponsors

Hospital Sant Joan de Deu
CollaboratorOTHER
University of Vic - Central University of Catalonia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
28 Weeks to 34 Weeks
Healthy volunteers
Yes

Inclusion criteria

* Preterm infants, gestational age between 28-34 weeks * Families with ability to take care of the child, without chronic or mental illness * Long-term parental presence in the hospital (at least 10h/day)

Exclusion criteria

* Children diagnosed with congenital disease or brain injury (LPV, HIV), before or during the study * Children undergoing major surgery (cardiac intervention, Ductus, thoracic intervention) * Children with musculoskeletal deformities

Design outcomes

Primary

MeasureTime frameDescription
Motor development.2 months corrected age and 8 months corrected ageAssessed by the Alberta Infant Motor Scale (AIMS). Total maximum score 40 points. Higher values represent a better outcome.

Secondary

MeasureTime frameDescription
Movement quality.40 weeks postmenstrual age and 2 months corrected ageAssessed by the General Movements Assessment. The assessment provide the quality of the movement (suboptimal/optimal/pathological).
Gross motor and fine motor function.8 months corrected ageAssessed by the Bayley Scale of Infant Development III. Percentile ranks from 1 to 99. Higher percentile represent a better outcome
Development and risk of development delay.1 months corrected age and 8 months corrected ageAssessed by the Ages and Stages Questionnaires Third Edition (ASQ-3). 30 questions covering 5 domains of development: communication, gross motor, fine motor, problem-solving and adaptive skills.
Mothers' stress index.after the intervention, 3 months corrected ageAssessed by the Parents Stress Index - Short Form. Composed of 36 items with a Likert-type answer format of five options.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026